Recent advances in antiviral therapy

Area of Science:

• Biomedical Research
• Virology
• Immunology

Background:

• The emergence of Human Immunodeficiency Virus (HIV) in the early 1980s transformed the landscape of virology research.
• Previously, specialist virology departments were under consideration, but HIV necessitated a greater focus on viral diseases and treatments.

Purpose of the Study:

• To highlight the impact of HIV on the advancement of virology and antiviral chemotherapy.
• To discuss the evolution of drug discovery methods and their application in developing antiviral therapies.
• To underscore the interdisciplinary collaborations fostered by HIV research.

Main Methods:

• Leveraging cloning and sequencing technologies to identify viral enzymes.
• Utilizing combinatorial chemistry for large-scale compound screening.
• Investigating immune system functions in the context of HIV infection.

Main Results:

• Significant progress in identifying viral targets and developing "designer drugs."
• Expansion of antiviral research beyond HIV to include herpesviruses, respiratory infections, and hepatitis B and C.
• Increased licensing of antiviral drugs, with approximately 20 approved since 1985, compared to two in 1985.

Conclusions:

• HIV has been a major catalyst for innovation in virology and antiviral drug development.
• Interdisciplinary approaches, particularly between virologists and immunologists, are crucial for tackling viral infections.
• The field has witnessed a substantial increase in the number of licensed antiviral medications, reflecting accelerated research and development.